COMPOUND ANTAGONIST VEGF AND ANTIPROLIFERATIVE AGENT Russian patent published in 2009 - IPC A61K31/00 A61K39/395 A61K38/17 A61K31/337 A61K33/24 A61P35/00 

Abstract RU 2353353 C2

FIELD: medicine.

SUBSTANCE: there is disclosed application of compound antagonist VEGF representing VEGFR1R2-FcΔCl(a) or Flt1D2. Flk1D3. FcΔCl (a) and antiproliferative agent: paclitaxel, docetaxel, or cisplatin, carboplatin, iproplatin for making a medical product for cancer treatment and/or tumour growth reduction or inhibition in an indigent person (versions), relevant method, pharmaceutical composition and a kit for cancer treatment.

EFFECT: overtotal effect of the disclosed combination (97% tumour suppression) observed without any by-effects.

10 cl, 2 dwg, 1 tbl

Similar patents RU2353353C2

Title Year Author Number
METHOD OF TREATING DISEASES BY VEGF ANTAGONISTS 2006
  • Shtal' Nejl
  • Jankopulos Dzhordzh D.
  • Ferfajn Ehrik
  • Sedarbaum Dzhess M.
RU2414924C2
ISOLATED MOLECULE OF NUCLEIC ACID, WHICH CODES FUSED POLYPEPTIDE THAT IS ABLE TO BIND VESSEL ENDOTHELIOCYTES GROWTH FACTOR (VEGF), FUSED POLYPEPTIDE, COPIED EXPRESSIVE VECTOR, METHOD FOR PRODUCTION OF FUSED POLYPEPTIDE, TRAP OF VEGF, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT AND SET FOR TREATMENT OF VEGF-MEDIATED DISEASE OR CONDITION 2004
  • Dejli Tomas Dzh.
  • Fehndl Dzhejms P.
  • Papadopulos Nikolas Dzh.
RU2376373C2
FUSED POLYPEPTIDE ABLE FOR BINDING WITH VEGF POLYPEPTIDE AND NUCLEIC ACID MOLECULE ENCODING THEREOF, THEIR PREPARING AND USING 2000
  • Papadopoulos Nikolas Dzh.
  • Dehvis Sehmjuel'
  • Jankopoulos Dzhordzh D.
RU2265661C2
NEUREGULIN ANTAGONISTS AND USE THEREOF IN TREATING MALIGNANT GROWTH 2011
  • Dzhekson Erika
  • Svit-Kordero Erik Alekhandro
RU2587619C2
COMBINATION CONTAINING COMBRETASTATIN AND CANCER AGENTS 2006
  • Bisseri Mari-Kristin
  • Vrin'O Patris'Ja
  • Demer Brizhitt
  • Shiron-Blondel' Mariell'
RU2396952C2
COMBINATIONS AND METHODS FOR ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY 2013
  • Disej Nejl P.
  • Soon-Shiong Patrik
RU2673805C2
THERAPEUTIC USE OF THE TLR AGONIST AND COMBINED THERAPY 2011
  • Khershberg Robert
  • Kukos Dzhordzh
  • Ditsh Gregori
  • Fachchjabene Andrea
  • Mandzharrez Kristi
  • Rendall Tressa D.
RU2603467C2
METHODS, COMPOSITIONS AND PRODUCTS FOR CANCER TREATMENT 2007
  • Gulati Anil
  • Reddi Guru
  • Lenaz Luidzhi
RU2407527C2
ANTI-ANGIOGENESIS THERAPY USED FOR TREATING BREAST CANCER 2009
  • Fajf Gvendolin
  • Fehn Si Chun'
  • Chzhou Sjan'
RU2531948C2
METHOD OF TREATING CANCER WITH DLL4 ANTAGONIST AND CHEMOTHERAPEUTIC AGENT 2010
  • Nogera-Troise Irene
  • Terston Gehvin
  • Tibo Alen
RU2571220C2

RU 2 353 353 C2

Authors

Khoulash Dzhoslin

Dzhaff Robert

Khu Limin'

Jankopulos Dzhordzh D.

Dates

2009-04-27Published

2004-07-23Filed